Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 92

1.

Closing the gap in surveillance of tuberculosis and HIV co-infection, and the need for clinician-public health alliances.

de Vries G, van den Hof S, Op de Coul E, van Crevel R.

Eur Respir J. 2018 Mar 22;51(3). pii: 1702671. doi: 10.1183/13993003.02671-2017. Print 2018 Mar. No abstract available.

PMID:
29567723
2.

Tuberculosis patients with unknown HIV status in the Netherlands: analysing underreporting and lack of testing.

Arnoldussen M, Schimmel H, Op de Coul E, van den Hof S, de Vries G.

Eur Respir J. 2017 Nov 16;50(5). pii: 1701257. doi: 10.1183/13993003.01257-2017. Print 2017 Nov. No abstract available.

PMID:
29146603
3.

Evaluation of tuberculosis screening of immigrants in the Netherlands.

van de Berg S, Erkens C, van Rest J, van den Hof S, Kamphorst M, Keizer S, de Vries G.

Eur Respir J. 2017 Oct 12;50(4). pii: 1700977. doi: 10.1183/13993003.00977-2017. Print 2017 Oct. No abstract available.

PMID:
29025892
4.

Evidence-based interventions to reduce tuberculosis stigma: a systematic review.

Sommerland N, Wouters E, Mitchell EMH, Ngicho M, Redwood L, Masquillier C, van Hoorn R, van den Hof S, Van Rie A.

Int J Tuberc Lung Dis. 2017 Nov 1;21(11):81-86. doi: 10.5588/ijtld.16.0788. Review.

PMID:
29025489
5.

Pharmacokinetics of Levofloxacin in Multidrug- and Extensively Drug-Resistant Tuberculosis Patients.

Van't Boveneind-Vrubleuskaya N, Seuruk T, van Hateren K, van der Laan T, Kosterink JGW, van der Werf TS, van Soolingen D, van den Hof S, Skrahina A, Alffenaar JC.

Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00343-17. doi: 10.1128/AAC.00343-17. Print 2017 Aug.

6.

Association between genotype and drug resistance profiles of Mycobacterium tuberculosis strains circulating in China in a national drug resistance survey.

Zhou Y, van den Hof S, Wang S, Pang Y, Zhao B, Xia H, Anthony R, Ou X, Li Q, Zheng Y, Song Y, Zhao Y, van Soolingen D.

PLoS One. 2017 Mar 23;12(3):e0174197. doi: 10.1371/journal.pone.0174197. eCollection 2017.

7.

Assessment of a 96-Well Plate Assay of Quantitative Drug Susceptibility Testing for Mycobacterium Tuberculosis Complex in China.

Xia H, Zheng Y, Zhao B, van den Hof S, Cobelens F, Zhao Y.

PLoS One. 2017 Jan 12;12(1):e0169413. doi: 10.1371/journal.pone.0169413. eCollection 2017.

8.

Predictors of Prolonged TB Treatment in a Dutch Outpatient Setting.

Van't Boveneind-Vrubleuskaya N, Daskapan A, Kosterink JG, van der Werf TS, van den Hof S, Alffenaar JC.

PLoS One. 2016 Nov 10;11(11):e0166030. doi: 10.1371/journal.pone.0166030. eCollection 2016.

9.

Risk of developing tuberculosis disease among persons diagnosed with latent tuberculosis infection in the Netherlands.

Erkens CG, Slump E, Verhagen M, Schimmel H, Cobelens F, van den Hof S.

Eur Respir J. 2016 Nov;48(5):1420-1428. doi: 10.1183/13993003.01157-2016. Epub 2016 Oct 6.

10.

The socioeconomic impact of multidrug resistant tuberculosis on patients: results from Ethiopia, Indonesia and Kazakhstan.

van den Hof S, Collins D, Hafidz F, Beyene D, Tursynbayeva A, Tiemersma E.

BMC Infect Dis. 2016 Sep 5;16:470. doi: 10.1186/s12879-016-1802-x.

11.

Variation in policy and practice of adolescent tuberculosis management in the WHO European Region.

Blok N, van den Boom M, Erkens C, Dara M, van den Hof S.

Eur Respir J. 2016 Sep;48(3):943-6. doi: 10.1183/13993003.00704-2016. Epub 2016 Jul 28. No abstract available.

12.

Programmatic Management of Drug-Resistant Tuberculosis: An Updated Research Agenda.

Mitnick CD, Rodriguez CA, Hatton ML, Brigden G, Cobelens F, Grobusch MP, Horsburgh R, Lange C, Lienhardt C, Oren E, Podewils LJ, Seaworth B, van den Hof S, Daley CL, Gebhard AC, Wares F; RESIST-TB (Research Excellence to Stop TB Resistance) and GDI (Global Drug Resistant TB Initiative).

PLoS One. 2016 May 25;11(5):e0155968. doi: 10.1371/journal.pone.0155968. eCollection 2016. Review.

13.

Correction: Impact on Patients' Treatment Outcomes of XpertMTB/RIF Implementation for the Diagnosis of Tuberculosis: Follow-Up of a Stepped-Wedge Randomized Clinical Trial.

Trajman A, Durovni B, Saraceni V, Menezes A, Cordeiro-Santos M, Cobelens F, Van den Hof S.

PLoS One. 2016 May 24;11(5):e0156471. doi: 10.1371/journal.pone.0156471. eCollection 2016.

14.

The Effects of Psycho-Emotional and Socio-Economic Support for Tuberculosis Patients on Treatment Adherence and Treatment Outcomes - A Systematic Review and Meta-Analysis.

van Hoorn R, Jaramillo E, Collins D, Gebhard A, van den Hof S.

PLoS One. 2016 Apr 28;11(4):e0154095. doi: 10.1371/journal.pone.0154095. eCollection 2016. Review.

15.

Cost-effectiveness of the Xpert® MTB/RIF assay for tuberculosis diagnosis in Brazil.

Pinto M, Steffen RE, Cobelens F, van den Hof S, Entringer A, Trajman A.

Int J Tuberc Lung Dis. 2016 May;20(5):611-8. doi: 10.5588/ijtld.15.0455.

PMID:
27084814
16.

Monitoring latent tuberculosis infection diagnosis and management in the Netherlands.

Erkens CG, Slump E, Verhagen M, Schimmel H, de Vries G, Cobelens F, van den Hof S.

Eur Respir J. 2016 May;47(5):1492-501. doi: 10.1183/13993003.01397-2015. Epub 2016 Feb 25. Erratum in: Eur Respir J. 2017 Jan 25;49(1):.

17.

No evidence that pyrazinamide resistance is acquired after fluoroquinolone resistance.

Cobelens F, Gebhard A, van den Hof S.

Int J Tuberc Lung Dis. 2016 Feb;20(2):282. doi: 10.5588/ijtld.15.0628. No abstract available.

PMID:
26792486
18.

Using existing data to illustrate--and close--the gap in access to new anti-tuberculosis drugs.

Mitnick C, van den Hof S.

Int J Tuberc Lung Dis. 2016 Feb;20(2):145. doi: 10.5588/ijtld.15.0911. No abstract available.

PMID:
26792461
19.

Elevated mortality after successful tuberculosis treatment.

van den Hof S, Borgdorff MW.

Int J Tuberc Lung Dis. 2016 Jan;20(1):2. doi: 10.5588/ijtld.15.0652. No abstract available.

20.

Correction: Impact of Replacing Smear Microscopy with Xpert MTB/RIF for Diagnosing Tuberculosis in Brazil: A Stepped-Wedge Cluster-Randomized Trial.

Durovni B, Saraceni V, van den Hof S, Trajman A, Cordeiro-Santos M, Cavalcante S, Menezes A, Cobelens F.

PLoS Med. 2015 Dec 3;12(12):e1001928. doi: 10.1371/journal.pmed.1001928. eCollection 2015 Dec. No abstract available.

Supplemental Content

Loading ...
Support Center